Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease
Faïza Bensemain(Inserm), Xavier Hermant(Inserm), Claudine Berr(Inserm), Ludovic Huot(Institut Pasteur), Julie Dumont(Inserm), Philippe Amouyel(Institut Pasteur de Lille), Christine Hubans(Celescreen (France)), Luc Buée(Inserm), Florence Pasquier, David Hot(Institut Pasteur), Julien Chapuis(Inserm), David M. A. Mann(Salford Royal NHS Foundation Trust), Franck Hansmannel(Inserm), Stéphanie Bombois(Université de Lille), Stéphanie Ferreira(Inserm), J-J Hauw(Inserm), Erwann Levillain(Institut Pasteur de Lille), Yves Lemoine(Institut Pasteur), C-A Maurage(Inserm)
Cited by 59
Related Papers
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
|The Lancet|2016|4.4k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.6k